Filter
1

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

for
Diffuse Large B Cell Lymphoma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18 - 70+

Code: NCT06687772

Phase2, Recruiting

Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

for
Relapsed and/or Refractory B-cell Lymphoma
Location: New York NY, Hackensack NJ, Montreal, Norfolk VA,
Sponsor: Kite, A Gilead Company

Sex: All

Age: 18+

Code: NCT04989803

Phase1, Phase2, Recruiting

A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

for
HPV-Related Cervical Carcinoma,
Location: Orlando FL, Tampa FL, Tulsa OK
Sponsor: Theravectys S.A.

Sex: All

Age: 18+

Code: NCT06319963

Phase1, Phase2, Recruiting

Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

for
Lung Neoplasm, Cell Hypoxia
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT00765986

Recruiting

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

for
B-cell Malignancy, Chronic Lymphocytic Leukemia,
Location: Worcester MA, Westbury NY, Baltimore MD, Durham NC,
Sponsor: Carna Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05602363

Phase1, Recruiting

Interested in new pancreatic cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Cognitive Training Intervention and Attitudes Towards Genetics

for
Cognitive Impairment, Hematologic Neoplasms,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 21+

Code: NCT03094026

Recruiting

Retifanlimab and Ruxolitinib In Solid Malignancies

for
Non Small Cell Lung Carcinoma, Renal Cell Carcinoma
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 0+

Code: NCT07219576

Phase1, Phase2, Recruiting

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

for
Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07215988

Recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

for
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma,
Location: New York NY, Pittsburgh PA, Detroit MI, Ann Arbor MI,
Sponsor: SciTech Development, Inc.

Sex: All

Age: 18+

Code: NCT04234048

Phase1, Recruiting

A Study of CRD3874-SI in People With Solid Tumors

for
Sarcoma, Merkel Cell Carcinoma
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06021626

Phase1, Recruiting

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

for
Non-Hodgkin Lymphoma, Burkitt Lymphoma,
Location: Valhalla NY
Sponsor: New York Medical College

Sex: All

Age: 3 - 31

Code: NCT02393157

Phase2, Recruiting

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

for
Carcinoma, Squamous Cell
Location: Boston MA, The Bronx NY, Staten Island NY,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 60+

Code: NCT04892173

Phase3, Recruiting

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

for
Peripheral T Cell Lymphoma
Location: New Brunswick NJ, Ottawa, Pembroke Pines FL, Toronto,
Sponsor: Acrotech Biopharma Inc.

Sex: All

Age: 18+

Code: NCT06072131

Phase3, Recruiting

Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

for
Small Cell Carcinoma of the Bladder,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06228066

Phase2, Recruiting

Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca

for
HPV-Related Squamous Cell Carcinoma
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT04988074

Phase2, Recruiting

Family Study of Lymphoproliferative Disorders

for
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70+

Code: NCT00626496

Recruiting

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

for
B-Cell Leukemia, Non-Hodgkin's Lymphoma,
Location: Ottawa, Toronto, Calgary, Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 1+

Code: NCT06208735

Phase1, Recruiting

Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma

for
Large B-cell Lymphoma, Relapse
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06919939

Phase2, Recruiting

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Boston MA, New Haven CT, New York NY, Paramus NJ,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06742996

Phase3, Recruiting

Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel

for
Non-Hodgkin Lymphoma, Large B-cell Lymphoma
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT05794958

Phase1, Recruiting